Fuchinoue, Kazuhiro
Nemoto, Tetsuo
Shimada, Hideaki http://orcid.org/0000-0002-1990-8217
Tochigi, Naobumi
Igarashi, Yoshinori
Yajima, Satoshi
Suzuki, Takashi
Oshima, Yoko
Shibuya, Kazutoshi
Article History
Received: 18 June 2019
Accepted: 1 October 2019
First Online: 8 October 2019
Compliance with ethical standards
:
: This study was approved by the Toho University Medical Center Omori Hospital Ethics Committee (Approval number: M18015). This retrospective observational study was performed by opt-out method on the web site of the Toho University Omori Medical Center.
: Dr. Shimada reports grants from TAIHO Pharmaceutical, Co. ltd., grants from Chugai Pharmaceutical, Co. ltd., personal fees from M3/CIWORKS, personal fees from ONO PHARMACEUTICAL CO., LTD., personal fees from Takeda Pharmaceutical Company Limited., grants from Eli Lilly Japan K.K, personal fees from DAIICHI SANKYO HEALTHCARE CO.,LTD., grants and personal fees from Yakult Honsha Co., Ltd., grants from Roche Diagnostics K.K., personal fees from Nippon Kayaku Co, Ltd, personal fees from Oncolys BioPharma Inc., personal fees from EA Pharma Co., Ltd., outside the submitted work;. the other authors have no conflict of interest to declare.